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Abstract: Caffeine consumption is a risk factor for osteoporosis, but the precise regulatory 
mechanisms are currently unknown. Here, we show that cell viability decreases in 
osteoblasts treated with caffeine in a dose-dependent manner. This cell death is attributed 
primarily to apoptosis and to a smaller extent, necrosis. Moreover, caffeine directly 
stimulates intracellular oxidative stress. Our data support caffeine-induced apoptosis in 
osteoblasts via a mitochondria-dependent pathway. The apoptotic biochemical changes 
were effectively prevented upon pretreatment with ROS scavengers, indicating that ROS 
plays a critical role as an upstream controller in the caffeine-induced apoptotic cascade. 
Additionally, p21-activated protein kinase 2 (PAK2) and c-Jun N-terminal kinase (JNK) 
were activated in caffeine-treated osteoblasts. Experiments further found that PAK2 
activity is required for caffeine-induced JNK activation and apoptosis. Importantly, our 
data also show that caffeine triggers cell death via inactivation of the survival signal, 
including the ERK- and Akt-mediated anti-apoptotic pathways. Finally, exposure of rats to 
dietary water containing 10~20 μM caffeine led to bone mineral density loss. These results 
demonstrate for the first time that caffeine triggers apoptosis in osteoblasts via activation 
of mitochondria-dependent cell death signaling and inactivation of the survival signal, and 
causes bone mineral density loss in vivo. 
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1. Introduction 
Caffeine and its related methyl xanthine products are widely distributed in plants, and people 
consume caffeine beverages every day. Common sources of caffeine include coffee, cocoa beans, cola 
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nuts and tea leaves. Caffeine is probably the most commonly consumed pharmacologically active 
compound in the world, particularly in Europe and North America. Each cup of tea, coffee, cocoa and 
cola contains 70 mg, 192 mg, 5 mg and 40 mg of caffeine, respectively [1]. The caffeine level is 
estimated as 21.22 μM in the blood circulation of people imbibing 2427 mg caffeine for 36 weeks [1]. 
However, it is difficult to determine the exact physiological concentration of caffeine. The use of 
caffeine as a risk factor for bone loss is currently a subject of controversy. Earlier studies disclose a 
negative effect of caffeine on calcium economy and caffeine-induced urinary calcium loss by increased 
diuresis [2, 3]. In addition, caffeine possibly increases the risk of osteoporosis, as deduced from the 
decrease in bone mineral density (BMD) [4], increase in hip fracture risk [5], and negative effects on 
calcium retention [6, 7]. While several studies show that caffeine-containing beverage consumption is 
associated with reduced bone mass and increased fracture risk, the precise mechanisms by which 
caffeine induces osteoporosis remain to be elucidated. 
The cytotoxicity of caffeine may be due to its ability to trigger apoptosis [8]. A number of cysteine 
proteases, known as caspases, play important roles in apoptosis [9, 10], similar to members of the Bcl-
2 family [11], which regulate mitochondrial membrane potential changes and the release of 
cytochrome C by modulating the outer mitochondrial membrane permeability. Moreover, changes in 
protein kinase activity are observed during apoptosis in a variety of cell types [12], indicating that 
phosphorylation is involved in cell death regulation. In particular, c-Jun N-terminal kinase (JNK) acts 
as a key component that regulates entry into apoptosis in several cell types [13-15]. In addition to JNK, 
p21-activated kinase (PAK) is activated during apoptosis, and may also be involved in signaling events 
[16-20]. While the direct downstream substrates of PAKs are largely unknown, recent studies suggest 
that these proteins act as upstream regulators of JNK and p38 MAPK pathways [21, 22].  
HSP90, a 90 kDa isoform of the HSP family proteins, acts in concert with other chaperones and 
partners to facilitate the maturation and folding of client proteins via formation of a HSP90/multi-
chaperone complex [23]. Two HSP90 client proteins, Raf-1 and MAPK/ERK kinase (MEK), are 
components of the Ras/extracellular signal regulated kinase (ERK)-dependent pathway that is involved 
in both proliferation and anti-apoptosis [24]. The second most important anti-apoptotic pathway 
involves Akt/PKB, another HSP90 client protein [25, 26]. The protective effect of Akt against 
apoptosis could be attributed to the modulation of mitochondria-dependent bcl-2 proteins [27]. 
However, there are no documented reports on the effects of caffeine on ERK- or Akt/PKB-mediated 
survival signaling in osteoporosis. 
To elucidate the precise regulatory mechanisms of caffeine-triggered cytotoxicity in osteoporosis, 
we examined the effects of caffeine on human osteoblasts. Based on the present results, we propose a 
model of caffeine-induced cell injury signaling in osteoblasts. In vivo experiments showed that 
caffeine consumption causes bone mineral density loss in an animal assay model, possibly as a result 
of cytotoxicity.  
2. Results and Discussion 
Previous studies show that caffeine induces various cell responses, including cell death [28]. 
However, the effects of caffeine on osteoblasts and osteoporosis are currently unclear. The potential 
cytotoxicity of caffeine was examined by determining the viability of human osteoblasts treated with Int. J. Mol. Sci. 2008, 9               
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various doses of the compound, using the MTT assay. Osteoblasts were incubated in medium 
containing 0-2 mM caffeine for 24 h. The viability of treated osteoblasts was decreased by 
approximately 10-35% at concentrations higher than 0.5 mM caffeine in a dose-dependent manner 
(Figure 1A). We further investigated whether caffeine-induced cell death represents apoptosis or 
necrosis. The percentage of apoptotic cells increased significantly in cultures exposed to >0.5 mM 
caffeine, and the necrotic cell population simultaneously increased at higher concentrations (Figures 
1B and C). These results indicate that treatment with caffeine triggers two cell death modes in 
osteoblasts, primarily apoptosis, and to a smaller extent, necrosis (Figures 1B and C). In addition, the 
DNA content of various cell cycle phases was determined by flow cytometry analysis of propidium 
iodide-labeled cells (Figure 1D). The decline in osteoblast survival ratio following treatment with 
caffeine was attributed to the simultaneous occurrence of G1 arrest, apoptosis and necrosis (Figures 1B 
and 1D). 
Figure 1. Effects of caffeine on osteoblasts. Osteoblasts were incubated with various 
concentrations of caffeine for 24 h. (A) Cell viability was determined using the MTT 
assay. (B) The percentages of apoptosis and necrosis were determined by propidium iodide 
and Hoechst 33342 staining. (C) Activity of LDH released in the culture medium of 
osteoblasts after treatment with various concentrations of caffeine for 24 h was measured. 
Data are expressed as a percentage of the maximal level (Max) of LDH activity determined 
after total cell lysis. (D) Osteoblasts were treated with or without 2 mM caffeine for 
various time periods as indicated. Cell cycle distribution of caffeine-treated osteoblasts 
was measured by flow cytometry analysis of propidium iodide-labeled cells. Values are 
presented as means ± SD of eight determinations. *P<0.05, **P<0.01 and ***P<0.001 
versus the untreated control group. 
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There is no documented evidence to show that caffeine directly provokes oxidative stress in cells. 
However, several reports demonstrate that ROS are effective cell injury inducers, leading to apoptosis 
and necrosis [29]. Therefore, we examined whether ROS formation occurs in caffeine-treated 
osteoblasts by immunostaining analysis with DCF-DA as the detection reagent. As shown in Figure 
2A, treatment with 0-2 mM caffeine for 24 h enhanced the intracellular ROS content in osteoblasts. 
ROS generation was additionally measured with DCF-DA and DHR-123 fluorescence dyes using the 
fluorescence ELISA reader (Figure 2B). In addition, ROS generation can detect when cells treatment 
with caffeine for more than 1 h (Figure 2C). To our knowledge, this is the first study to show that 
caffeine directly induces ROS generation in osteoblasts.  
Figure 2. Caffeine induces ROS generation in osteoblasts. Osteoblasts were incubated 
with 20 μM DCF-DA or dihydrorhodamine 123 (DHR 123) for 1 h, and treated with 
various concentrations of caffeine for another 2 h. (A) Cells were observed using a 
fluorescence microscope at 100-fold magnification under fluorescence illumination. (B) 
ROS generation was assayed by DCF-DA or DHR 123 fluorescence, and expressed as 
absorbance/mg of protein. (C) Osteoblasts were treated with 2 mM caffeine for various 
time periods as indicated. ROS generation was assayed by DCF-DA or DHR 123 
fluorescence. Values are presented as means ± SD of eight determinations. **P<0.01 and 
***P<0.001 versus untreated control group. 
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The protein expression ratio of Bax versus Bcl-2 is relevant to apoptosis. Specifically, a high 
Bax/Bcl-2 ratio is associated with a lower threshold of apoptosis, while a low ratio represents a higher 
apoptotic threshold [30, 31]. Here, we investigate whether caffeine induces apoptosis by modulating Int. J. Mol. Sci. 2008, 9               
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the Bax/Bcl-2 ratio, the major effectors of mitochondria-mediated apoptosis. Immunoblotting revealed 
that treatment of osteoblasts with more than 0.5 mM caffeine triggered an increase in Bax and decrease 
in Bcl-2 protein levels (Figure 3A). Densitometric analysis quantitatively revealed that caffeine-treated 
osteoblasts have a higher Bax/Bcl-2 ratio, favoring apoptosis (Figure 3B).  
Bax and Bcl-2 regulate changes in the mitochondrial membrane potential (MMP) and permeability, 
which play important roles in apoptotic processes [32]. As mitochondrial membrane potential change 
is directly associated with apoptosis [33-35], we further investigated the effects of caffeine on this 
parameter. Treatment of osteoblasts with caffeine decreased DiOC6(3) and TMRE uptake into 
mitochondria, indicating that caffeine induces significant loss of mitochondrial membrane potential 
(Figure 3C). In addition, we also found that loss of MMP was detectable when cells treatment with 
caffeine for more than 6 h (Figure 3D). Our findings support the theory that caffeine triggers apoptosis 
via a mitochondria-dependent pathway. 
Figure 3. Caffeine induces an increase in the ratio of Bax/Bcl-2 protein level and loss 
of MMP in osteoblasts. Osteoblasts were incubated with various concentrations of 
caffeine for 24 h. (A) Extracts (40 μg) were analyzed by immunoblotting with anti-Bcl-2 
or Bax antibodies. (B) Bax and Bcl-2 levels were analyzed using densitometry. (C) MMP 
changes were analyzed with 40 nM DiOC6(3) or 1 μM TMRE. (D) Osteoblasts were 
treated with 2 mM caffeine for various time periods as indicated. MMP changes were 
analyzed with 40 nM DiOC6(3) or 1 μM TMRE. Values are presented as means ± SD of 
eight determinations. **P<0.01 and ***P<0.001 versus untreated control group. 
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Caspases play important roles in apoptosis, and their activation is critical in biochemical changes 
for cell death analysis [9, 10]. For identifying the signaling pathways involved in caffeine-induced cell Int. J. Mol. Sci. 2008, 9               
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death, we used an immunoblotting assay to monitor the levels of caspases-9 and -3, which are 
activated during the apoptosis of multiple cell types triggered by various stimuli [36, 37]. Treatment of 
osteoblasts with caffeine stimulated caspase-9 and -3 activities (Figures 4A-4D). The activation of 
caspase-9 and caspase-3 were detectable when cells treatment with caffeine for more than 9 h (Figure 
4B and 4D). Poly(ADP-ribose)polymerase (PARP) is a key participant in DNA base excision repair. 
Apoptosis is accompanied by early and unique cleavage of PARP. The formation of a 89 kDa cleavage 
fragment resulting from the specific PARP cleavage pattern is a hallmark of apoptosis. Here, we show 
that PARP, a specific caspase-3 substrate, is cleaved in caffeine-treated osteoblasts (Figure 4E). 
Accordingly, we propose that caffeine-triggered apoptosis occurs via caspase-9 and caspase-3 
activation.  
Figure 4. Activation of caspase-9 and caspase-3 in caffeine-treated osteoblasts. 
Osteoblasts were incubated with various concentrations of caffeine for 24 h. Cell extracts 
(40 μg) were immunoblotted using anti-caspase-9 (A), anti-caspase-3 (C), or anti-PARP 
(E) antibodies. P89 (89 kDa) represents the cleavage product of PARP. Caspase-9 activity 
was also assayed using the Colorimetric Caspase-9 Assay Kit (A; upper panel). The same 
cell extracts (60  μg) were analyzed for caspase-3 activity, using Z-DEVD-AFC as the 
substrate (C; upper panel). (B and D) Osteoblasts were treated with 2 mM caffeine for 
various time periods as indicated. Caspase-9 (B) and caspase-3 activities (D) were 
measured. 
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To further clarify the role of ROS in caffeine-induced apoptosis, we assessed the effects of two 
commonly used ROS scavengers, N-acetyl cysteine (NAC) and α-tocopherol, on caffeine-treated 
osteoblasts. Pretreatment of cells with α-tocopherol (300 μM) or NAC (500 μM) attenuated caffeine-
induced intracellular ROS generation, loss of MMP, and caspase-3 activation (Figures 5A, B and C). 
Based on the results, we propose that caffeine triggers ROS generation, which in turn activates 
mitochondria-dependent apoptotic processes in osteoblasts.  
Figure 5. Effects of ROS scavengers on caffeine-treated osteoblasts. Osteoblasts were 
treated with or without the indicated concentrations of α-tocopherol (Toc; 300 μM) or N-
acetyl cysteine (NAC; 500 μM) for 30 min, followed by incubation with caffeine (2 mM) 
for another 24 h. ROS generation (A), MMP changes (B), and caspase-3 activities (C) 
were measured. Values are presented as means ± SD of eight determinations. ***P<0.001 
versus untreated control group. #P<0.001 versus “caffeine-treatment only” group. 
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Previous studies show that p21-activated protein kinase 2 (PAK2) is activated during cell death, and 
may be involved in apoptotic signaling events, possibly via caspase-3-directed proteolysis [18-20]. We 
investigated whether PAK2 cleavage/activation occurs in caffeine-treated osteoblasts. Immunoblotting 
and immunoprecipitation kinase activity assays revealed that caffeine induces PAK2 cleavage (Figure 
6A) and activation (Figure 6B), respectively. Caspase-3 is activated during apoptosis of several cell 
types triggered by a variety of stimuli, including anti-Fas antibodies, TNF-α, and the chemotherapeutic 
agent, etoposide [36, 37]. To elucidate the relationship between caspase-3 activation and PAK2 during 
caffeine-induced apoptosis, we examined the effects of the specific tetrapeptidic caspase inhibitors, 
Ac-DEVD-cho and Ac-YVAD-cmk [18, 20], on caffeine-treated osteoblasts. Caffeine-induced 
activation of caspase-3 was markedly suppressed upon pretreatment with either of the inhibitors Int. J. Mol. Sci. 2008, 9               
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(Figure 6C). Pretreatment with caspase inhibitors additionally blocked caffeine-induced PAK2 activity 
(Figure 6D), indicating that caspase-3 functions upstream of PAK2 in the apoptotic pathway.  
Figure 6. Caffeine induces the cleavage/activation of PAK2. Osteoblasts were incubated 
with various concentrations of caffeine for 24 h. (A) Cell extracts (60 μg) were 
immunoblotted with anti-αPAK (C19) antibody. (B) PAK2 was immunoprecipitated, and 
kinase activities were assayed using myelin basic protein as the substrate. (C and D) 
Osteoblasts were preincubated in the presence or absence of 300 μM Ac-DEVD-cho or 
Ac-YVAD-cmk for 1 h, and then incubated with 2 mM caffeine for another 24 h. Caspase-
3 (C) and PAK2 (D) activities were measured. Values are presented as means ± SD of five 
determinations. *P<0.05 and ***P<0.001 versus the untreated control group. #P<0.001 
versus caffeine treatment group. 
A
Caffeine     0         0.25       0.5          1           2     mM
PAK2
PAK2C
PAK1
β-Actin
 
0
2
4
6
8
10
12
14
16
00 . 2 5 0 . 5 1 2
B
P
A
K
2
 
A
c
t
i
v
i
t
y
(
C
o
n
t
r
o
l
=
1
.
0
0
)
Caffeine (mM)
*
* *
*
* *
*
C
0
200
400
600
800
1000
1200
1400
Inhibitor       －－ DEVD        YVAD
Caffeine        0                  2                 2           2          (mM)
C
a
s
p
a
s
e
-
3
 
A
c
t
i
v
i
t
y
#
#
*
*
*
 
D
0
2
4
6
8
10
12
14
16
18
Inhibitor      －－ DEVD        YVAD
Caffeine        0                  2                  2          2          (mM)
#
#
*
* *
P
A
K
2
 
A
c
t
i
v
i
t
y
(
C
o
n
t
r
o
l
=
1
.
0
0
)
 
Activation of JNK is essential for apoptotic induction in some cell types [13, 14], and in earlier 
investigations, we demonstrate that UV irradiation-, methylglyoxal-, and high glucose-induced 
apoptosis are mediated by JNK [38-40]. Here, we use immunoblotting and ELISA assays to examine 
JNK activation during caffeine-induced apoptosis. JNK activity was stimulated in osteoblasts treated 
with caffeine (Figure 7A). To further determine the relationship between JNK and PAK2 and the 
functional role of PAK2 in caffeine-induced apoptosis, we incubated osteoblasts with antisense or 
sense oligonucleotides against PAK2 for 3 days, subjected cells to caffeine treatment, and analyzed 
cell extracts by immunoblotting with anti-PAK2 (N17) antibodies and immunoprecipitation. Pre-
incubation of osteoblasts with an antisense oligonucleotide against PAK2 led to a significant decrease 
in PAK2 protein levels (by ~40%), compared to untreated controls, whereas the sense oligonucleotide 
had no such effect (Figure 7B). Similarly, cells treated with the antisense PAK2 oligonucleotide 
displayed PAK2 activation levels that were approximately 40% those of control cells (Figure 7B). 
These reductions in PAK2 protein expression and activation were associated with a significant Int. J. Mol. Sci. 2008, 9               
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decrease in caffeine-induced activation of JNK and apoptosis (Figures 7C and 7D). Furthermore, 
activation of JNK was markedly reduced in the presence of the caspase-3 inhibitors (Figure 7E). 
However, caspase inhibitors had no effects on ROS generation in caffeine-treated osteoblasts (data not 
shown). Our findings support the theory that ROS generation is an upstream regulator of sequential 
apoptotic biochemical changes, such as caspase activation.  The data strongly suggest that PAK2 
activation plays an important role in caffeine-induced JNK activation and apoptosis of osteoblasts.  
Figure 7. Active PAK2 is required for JNK activation in caffeine-induced apoptosis. 
(A) Osteoblasts were incubated with various concentrations of caffeine for 24 h. Cell 
extracts (60 μg) were prepared and immunoblotted with the anti-p-JNK antibody. JNK/AP-
1 activity was additionally evaluated by ELISA analysis of phosphorylated c-Jun. Results 
are expressed with respect to untreated control values arbitrarily set to 1.00. (B-D) 
Osteoblasts were transfected with 70 μM PAK2 sense (S) or antisense (AS) 
oligonucleotides for 72 h, followed by 2 mM caffeine for another 24 h. PAK2 activity (B), 
JNK activity (C) and cell apoptosis (D) were measured. (E) Osteoblasts were preincubated 
in the presence or absence of 300 μM Ac-DEVD-cho or Ac-YVAD-cmk for 1 h, and then 
incubated with 2 mM caffeine for another 24 h. JNK/AP-1 activity was measured. 
**P<0.01 and ***P<0.001 versus untreated control group. #P<0.001 versus “caffeine-
treatment only” group. 
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Analysis of the results in Figure 7 reveals that the decreased ratios of PAK2 (~57%) and JNK 
activity (~54%) are higher than that of apoptosis inhibition (~36% decrease) in caffeine-treated cells. 
This finding indicates that other regulatory mechanisms are additionally involved in caffeine-induced 
apoptosis in osteoblasts.  
Survival signaling processes protect against apoptosis induced by specific stimuli [41, 42]. Our 
group and others have demonstrated that some apoptotic stimuli inhibit the Ras→ERK survival signal 
pathway by decreasing the protein levels of various survival components [31, 42, 43]. Based on these 
results, we evaluated the effects of caffeine on the cell survival signal pathway, including activities of 
components critical for the Ras→ERK-dependent and PI3 Kinase→Akt survival signal pathways. Our 
results show that caffeine triggers a decrease in the protein levels of HSP90, Ras, Raf-1, and Akt, and 
inhibition of ERK and Akt activities (Figure 8A). In addition, inhibition of protein expression or 
activities of these survival signal components by caffeine could be effectively blocked by pretreatment 
with lactacystin, a specific proteasome inhibitor, and NAC, a potent ROS scavenger (Figure 8A). 
Moreover, lactacystin and NAC prevented caffeine-induced cell apoptosis, which correlates the 
blocking of survival signal components decreases (Figures 8A and B). These data imply that Ras, Raf-
1, and Akt are degraded by ROS and proteasome-dependent pathways in caffeine-treated osteoblasts, 
subsequently reducing ERK and Akt activities for cell apoptosis.  
Figure 8. Effects of caffeine on HSP90 and components of survival signaling. 
Osteoblasts were incubated with or without lactacystin (LC; 10 μM) or NAC (500 μM) for 
1 h, and treated with caffeine (2 mM) for another 24 h. (A) The protein levels of HSP 90, 
Raf-1, ERK-1/2 and Akt, and phosphorylation of ERK-1/2 and pGSK3 were evaluated. β-
actin was used as the loading control. (B) Cell apoptosis was detected with the TUNEL 
assay. Data are representative of five independent experiments. **P<0.01 and ***P<0.001 
versus “caffeine-treatment only” group. 
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Lastly, we analyzed whether the apoptotic effect of caffeine on osteoblasts induces bone density 
injury in vivo. Wistar rats were fed a standard diet supplemented with or without caffeine (10 or 20 Int. J. Mol. Sci. 2008, 9               
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μM) in drinking water for 8 months. Initial body weights were similar among the control and caffeine-
treated groups, and did not differ significantly at the end of the 8-month experimental period (data not 
shown). However, the bone mineral densities (BMD) of whole femurs and distal femurs from rats in 
the caffeine-treated groups were significantly lower than those in the control (caffeine-free) group 
(Figure 9). These results suggest that elevated caffeine levels, resulting from continuous long-term 
consumption of high caffeine-containing foods, negatively affect BMD, an important osteoporosis 
indicator.  
Figure 9. Effects of caffeine intake on BMD of rats. DXA was used to assess BMD in 
whole femurs and distal femurs of rats fed a controlled diet with or without caffeine (10 or 
20 μM) in the drinking water for 8 months. Values are presented as means ± SD of five 
determinations. *P＜0.05 versus “caffeine-free” group. 
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Substantial amounts of caffeine are ingested by people drinking coffee, tea or caffeinated soft 
drinks. While the consumption of caffeine-containing beverages is associated with significantly 
increased osteoporosis risk, its precise role and regulatory mechanisms in bone loss and fracture risk 
are currently unclear [44]. Our current results provide evidence that the apoptotic and necrotic 
properties of caffeine contribute to bone loss and osteoporosis in osteoblasts. The majority of caffeine-
treated cells die via apoptotic processes through ROS generation and a mitochondria-mediated 
pathway, while a minor proportion of cell death occurs through necrosis (Figures 1-3).  
Oxidative stress is a stimulator of cell responses such as apoptosis [29, 45]. Importantly, caffeine 
directly induced oxidative stress in osteoblasts in our study (Figure 2). In addition, pretreatment with 
antioxidants effectively prevented ROS-induced apoptotic biochemical changes (Figure 4). Several 
reports show that ROS is an important upstream regulator of JNK and caspase activation during UV-, 
methylglyoxal-, and osmotic shock-induced apoptosis in various mammalian cells [38, 40, 46]. These 
results, coupled with our findings, strongly imply that oxidative injury plays a pivotal role in caffeine-
induced apoptosis. However, the underlying mechanisms of caffeine-triggered ROS formation remain 
to be established. The effects of caffeine on target cells may depend, at least in part, on cell type and 
treatment protocol (i.e., treatment period and dosage). 
Mitochondria act as important conduits for signals during programmed cell death, and loss of 
mitochondrial integrity can be promoted or inhibited by several key regulators of apoptosis [47, 48]. 
For instance, various cellular stress conditions, including heat shock, DNA damage and oxidative 
stress, result in caspase activation through cytochrome c release from the mitochondrial Int. J. Mol. Sci. 2008, 9               
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intermembrane space into the cytoplasm [48, 49]. We examined Bax/Bcl-2 protein expression and 
MMP changes, with a view to further elucidating the precise mechanisms of caffeine-induced 
apoptosis. Caffeine triggered an increase in Bax/Bcl-2 protein expression and loss of MMP in a dose-
dependent manner (Figures 3A-3C). Moreover, caspases-9 and -3 were activated in the presence of 
caffeine (Figure 4). Interestingly, caffeine induced ROS generation and activation of caspase-9 and 
caspase-3 at concentrations higher than 0.5 mM, but had no effects on MMP changes or the Bax/Bcl-2 
ratio at 0.5 mM (Figures 2, 3 and 4). These ambiguous results may be affected by the different assay 
sensitivities of various methods or assay kits. To elucidate the underlying reasons for these conflicting 
results, we further analyzed Bax and Bcl-2 mRNA levels by real-time PCR. Our analyses revealed that 
caffeine treatment of osteoblasts led to increased and decreased Bax and Bcl-2 expression levels at 
concentrations higher than 0.5 mM, respectively (data not shown). Thus, apoptotic biochemical 
changes, such as ROS generation, MMP changes, and activation of caspases appear to be correlated. In 
addition, inhibition of ROS generation by antioxidants was associated with a decrease in caffeine-
triggered mitochondria-dependent apoptotic changes (Figure 5). Accordingly, we propose that ROS act 
as important regulators of mitochondria-dependent apoptotic processes promoted by caffeine.  
Recently, coworkers of our laboratory and other researchers showed that PAK2 is a target substrate 
for caspases activated by various apoptotic stimuli [17-19, 50]. However, the functional role of the 
caspase-generated C-terminal active fragment of PAK2 remains obscure. Our group showed that 
decreases in PAK2 protein expression and activation are associated with significant inhibition of 
methylglyoxal-induced apoptosis in human osteoblasts [30], strongly suggesting that PAK2 plays an 
important role in apoptosis by methylglyoxal. Here, we demonstrate the PAK2 is an important 
upstream regulator of JNK activation in caffeine-directed apoptosis of osteoblasts (Figures 6 and 7). 
JNK evidently plays critical roles in apoptosis [14, 15]. Moreover, inhibition of caspase-3 blocks 
activation of PAK2 and JNK (Figures 6C, 6D, and 7E). Based on these results, we propose that 
caffeine triggers caspase-3 activation, which in turn induces cleavage/activation of PAK2 and 
sequential activation of JNK, consequently leading to apoptosis.  
Heat-shock proteins (HSP) protect proteins against proteasome- and ubiquitin-dependent 
degradation [51, 52]. HSP90, the most abundant molecular chaperone protein in the intracellular 
system, is involved in maintaining the correct conformation of intracellular proteins and kinases, such 
as Raf-1 and Akt [53, 54], which regulate cell proliferation and survival. Here, we show that caffeine-
induced apoptosis is associated with reduced expression of survival components, including Ras, Raf-1, 
and Akt. Moreover, inactivation of ERK-1, ERK-2 and Akt/PKB, and pretreatment with lactacystin, a 
proteasome inhibitor, may prevent these decreases in protein level or activity (Figure 8A). Caffeine 
suppresses HSP90 expression, thus promoting the degradation of client proteins (Figure 8A). 
Accordingly, we hypothesize that the caffeine-induced reduction of HSP90 stimulates Ras, Raf-1 and 
Akt targeting for degradation, leading to their downregulation and changes in the related signal 
pathways. In view of these findings, the following pathway is proposed: caffeine decreases HSP90 
expression, leading to increased degradation of Ras, Raf-1 and Akt/PKB, with decreased Raf-1 levels 
resulting in ERK-1 and ERK-2 downregulation and subsequent cell apoptosis. ROS generation is 
additionally involved in caffeine-induced suppression of the levels of survival signal proteins (Figures 
8A and B). Thus, it appears that ROS act as upstream negative regulators of Ras→ERK and PI3K→Int. J. Mol. Sci. 2008, 9               
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Akt/PKB survival signals in caffeine-induced apoptosis. However, the precise regulatory mechanisms 
require further investigation. 
Lastly, given the ability of caffeine to induce apoptosis or cell injury in osteoblasts in vitro, we 
examined its effects on bone density in an animal assay model. Rats administered 10 or 20 μM 
caffeine in the drinking water for 8 months displayed significantly decreased bone mineral density 
(BMD), compared to untreated control rats, further signifying that caffeine consumption negatively 
affects bone density (Figure 9).  
3. Conclusions 
Recent study by our group found that the common signaling pathway in caffeine-stimulated cell 
injury occurs not only in the human osteoblast cell line, but also mouse osteoblast primary cultures and 
cell lines. The current results establish that caffeine-induced ROS trigger cell injury through apoptosis, 
necrosis and inactivation of survival signal components. In addition, a time-course study of various 
apoptotic biochemical changes indicates that ROS act as upstream regulators for MMP loss, which 
further triggers caspase activation for sequential apoptotic processes, such as activation of PAK2 and 
JNK. Based on these findings, we propose a model of caffeine-induced cell injury signaling in 
osteoblasts and possible effects on osteoporosis (specified in Figure 10). Our findings provide 
preliminary evidence that high consumption of caffeine is a significant risk factor in osteoporosis. 
4. Experimental Section 
Chemicals 
Caffeine, 2’,7’-dichlorofluorescein diacetate (DCF-DA), propidium iodide, and Annexin V were 
purchased from Sigma (St. Louis, MO). Anti-phospho-JNK, Bax, caspase-3 and PAK2 antibodies were 
obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-poly (ADP-ribose) polymerase 
(PARP), Bcl-2, and caspase-9 antibodies were from Cell Signaling Technology (Beverly, MA). MTT 
[3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide] and the cell death detection 
ELISA
plus kit were acquired from Roche Applied Science (Germany). The BCA protein assay kit was 
purchased from Pierce Biotechnology (Rockford, IL, USA). 
Cell culture and caffeine treatment 
The human osteoblast cell line, hFOB 1.19, was cultured according to the standard procedures of 
American Type Culture Collection (ATCC). Cells were seeded in 1:1 mixture of Ham’s F12 medium 
and Dulbecco’s modified Eagle’s medium (DMEM/F12) without phenol red containing 2.4 mM L-
glutamine, 0.3 mg/ml G418, and 10% fetal bovine serum media. Cultures were maintained at 34°C 
with a gas mixture of 5% CO2/95% air. For caffeine treatment, cells (~5-6 x 10
6) were plated on 60 
mm culture dishes, and incubated in medium containing various concentrations of caffeine for 24 h. 
Next, cells were washed twice with ice-cold PBS, and lysed in 600 μl of lysis solution (20 mM Tris-
HCl, pH 7.4, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 1 mM benzamidine, 1 mM 
phenylmethylsulfonyl fluoride, 50 mM NaF, 20 mM sodium pyrophosphate and 1 mM sodium 
orthovanadate) on ice for 10 min. Cell lysates were collected, sonicated on ice for 3 × 10 sec, and Int. J. Mol. Sci. 2008, 9               
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centrifuged at 15,000 × g for 20 min at 4
oC. The resulting supernatant fractions were used as cell 
extracts. 
Figure 10. Summary of events occurring during caffeine-induced cytotoxicity in osteoblasts. 
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MTT assay 
The MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) test is a colorimetric 
assay that measures the percentage of cell survival. Caffeine-treated cells were treated with 100 μl of 
0.45g/l MTT solution per dish, and incubated at 37
oC for 60 min. This was followed by treatment with 
100 μl of 20% SDS in DMF:H2O (1:1), and overnight incubation at 37
oC. Spectrophotometric data 
were measured using an ELISA reader at a wavelength of 570 nm. 
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Assessment of necrosis and apoptosis 
Oligonucleosomal DNA fragmentation in apoptotic cells was measured using the Cell Death 
Detection ELISA
plus kit, according to the manufacturer’s protocol (Roche Molecular Biochemicals, 
Mannheim, Germany). Cells (1×10
5) were treated with or without the indicated concentrations of 
caffeine at 37
oC for 24 h, and spectrophotometric data obtained with an ELISA reader at 405 nm. 
Necrosis and apoptosis were further assayed by staining with propidium iodide and Hoechst 33342. 
Specifically, cells were incubated with propidium iodide (1 μg/ml) and Hoechst 33342 (2 μg/ml) at 
room temperature for 10 min. Under a fluorescence microscope, propidium iodide-negative cells 
(having intact plasma membranes that exclude the dye) displaying condensed/fragmented nuclei 
stained with Hoechst 33342 were identified as apoptotic, whereas propidium iodide-positive cells were 
necrotic. In each experiment, 8-10 independent fields (~600-1000 nuclei in total) were counted per 
condition, and the cell percentages calculated. Necrosis was additionally assayed by measurement of 
lactate dehydrogenase (LDH) activity in the culture medium [55]. Cells were cultured in 96-well 
microtiter plates (100 μl medium/well), and absorption values at 490 nm were determined with an 
ELISA reader, according to the manufacturer’s instructions (Promega, Madison, WI). Blanks consisted 
of samples containing test substances and cell-free medium. 
ROS assay 
ROS levels were measured in arbitrary units using 2’,7’-dichlorofluorescein diacetate (DCF-DA) 
and dihydrorhodamine 123 (DHR 123) dye. Cells (1.0×10
6) were incubated in 50 μl PBS containing 20 
μM DCF-DA or DHR-123 for 1 h at 37
oC, and the relative ROS units determined using a fluorescence 
ELISA reader (excitation at 485 nm; emission at 530 nm). An aliquot of the cell suspension was lysed, 
and the protein concentration estimated. Results are expressed as arbitrary absorbance units/mg protein. 
Immunoblots 
Immunoblotting was performed essentially as described in a previous report by our group [46]. 
Briefly, proteins were resolved by SDS-PAGE, transferred to PVDF membranes, and immunoblotted 
with anti-Bax, anti-Bcl-2, anti-caspase-3, anti-caspase-9, anti-poly (ADP-ribose) polymerase (PARP), 
anti-PAK (c-19), anti-JNK and anti-phospho JNK antibodies (0.25 μg/ml). Proteins of interest were 
detected with secondary alkaline phosphatase-conjugated goat anti-rabbit or anti-mouse IgG antibodies, 
and visualized using the CDP-Star
TM chemiluminescent substrate, according to the manufacturer’s 
protocol.  
Detection of mitochondrial membrane potential (MMP) 
Osteoblasts were dispensed into 96-well plates, grown for 24 h, and incubated with various 
concentrations of caffeine for 24 h. Fluorescent dyes, DiOC6(3) (20 nM) or TMRE (0.1  μM), were 
added to each well, incubated for 15 min, and fluorescence measured with a plate spectrofluorometer 
[excitation: 485 nm (DiOC6(3)) or 535 nm (TMRE); emission: 535 nm (DiOC6(3)) or 590 nm 
(TMRE)].  Int. J. Mol. Sci. 2008, 9               
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Caspase activity assays 
Caspase-9 activity was determined using the Colorimetric Caspase-9 Assay Kit (Calbiochem, CA). 
Caspase-3 activity was measured using the Z-DEVD-AFC fluorogenic substrate, as described 
previously [30, 56].  
Immunoprecipitation and PAK2 activity assays 
Prior to immunoprecipitation, cell extracts were diluted with cell lysis solution to a protein 
concentration of 1.0 mg/ml. For immunoprecipitation of the C-terminal catalytic fragment of PAK2, 
0.5 ml of cell extracts was incubated with 10 μl of anti-PAK2 (C15) antibody (200 μg/ml) at 4°C for 
1.5 h, and further incubated with 40 μl of Protein A-Sepharose CL-4B (30%, v/v) for 1.5 h with 
shaking. Immunoprecipitates were collected by centrifugation, washed three times with 1 ml of 
Solution A (20 mM Tris/HCl, pH 7.0, and 0.5 mM DTT) containing 0.5 M NaCl, and resuspended in 
40 μl of Solution A. For measurement of PAK2 activity, immunoprecipitates were incubated in a 50 μl 
mixture containing 20 mM Tris/HCl, pH 7.0, 0.5 mM DTT, 0.2 mM [γ-p
32]ATP, 20 mM MgCl2 and 
0.1 mg/ml myelin basic protein at room temperature for 10 min with shaking. For determination of 
32P 
incorporation into myelin basic protein, 20 μl of each reaction mixture was spotted onto Whatman P81 
paper (1 × 2 cm), washed with 75 mM phosphoric acid and processed, as described previously [57]. 
JNK activity assay 
JNK activity, measured by the presence of phosphorylated c-Jun protein, was analyzed using the 
AP-1/c-Jun ELISA kit, according to the manufacturer’s protocol (Active Motif, Carlsbad, CA). Briefly, 
AP-1 heterodimeric complexes in cellular nuclear extracts were collected by binding to the consensus 
5’-TGA(C/G)TCA-3’ oligonucleotide coated on a 96-well plate. Phospho-c-Jun was assayed using a 
specific primary antibody and secondary horseradish peroxidase-conjugated antibody in a colorimetric 
reaction.  
Inhibition of PAK2 by antisense oligonucleotides 
PAK2 sense (5’-ATC ATG TCT GAT AAC GGA GAA) and antisense (5’-TTC TCC GTT ATC 
AGA CAT GAT) oligonucleotides (representing amino acids -1 to +7 of human PAK2) were obtained 
from Life Technologies (Grand Island, NY). Oligonucleotides were synthesized under 
phosphorothioate-modified conditions, purified by HPLC, and dissolved in 30 mM HEPES buffer, pH 
7.0. For transfection, cells grown in 60 mm culture dishes were incubated at 37°C in 1 ml of Opti-
MEM I medium (modified Eagle's minimum essential medium buffered with HEPES and sodium 
bicarbonate) containing lipofectAMINE4 (12 μg) and oligonucleotides (70 μM) for 72 h (all reagents 
from Life Technologies, Grand Island, NY). Cells were treated with 2 mM caffeine, and extracts were 
analyzed as described above. Int. J. Mol. Sci. 2008, 9               
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AKT kinase assay 
Cell extracts were incubated and immunoprecipitated with 10 μl of anti-Akt monoclonal antibody 
(200 μg/ml). Details of the procedure are described in Section 2.9. Briefly, immunoprecipitates were 
incubated with 1 mg GSK-3 fusion protein (Cell Signaling Technology) in the presence of 200 mM 
ATP and reaction buffer (25 mM TRIS, pH 7.5, 5 mM β glycerophosphate, 2 mM dithiothreitol, 0.1 
mM sodium orthovanadate, and 10 mM MgCl2) at 30
oC for 30 min. The reaction mixture was analyzed 
with 12.5% SDS-PAGE, and immunoblotted with anti-phospho-GSK-3α/β (Ser21/9) rabbit polyclonal 
antibody.  
Animals, diets, and bone mineral density measurement 
The effects of caffeine intake on bone mass were analyzed in 18 week-old female Wistar rats. Rats 
were randomly divided into three diet groups of 10 animals each. Group one was administered a 
standard diet, Group two fed a standard diet supplemented with 10 μM caffeine in the drinking water, 
and Group Three given a standard diet supplemented with 20 μM caffeine in the drinking water. Rats 
were exposed to caffeine-containing or control drinking water for 8 months, and the right femur of 
each rat was analyzed for bone mineral density (BMD) using dual energy X-ray absorptiometry (DXA). 
In vivo reproducibility was evaluated by measuring the coefficient of variation over five repeat 
experiments, and rats repositioned between readings. The same researcher conducted all DXA scans 
and analyses. 
Statistics 
Data were analyzed using one-way ANOVA. Differences were evaluated using the Student’s t-test 
and analysis of variance. Data are presented as means ± SD. P < 0.05 was defined as a significant 
difference. 
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